Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma

被引：4
|
作者：
Yousef, Samer
Joy, Christopher
Velaiutham, Shanta
Maclean, Fiona M.
Harraway, James
Gill, Anthony J.
Vargas, Ana Cristina
机构：
来源：
PATHOLOGY | 2022年 / 54卷 / 03期
关键词：
PRAME;
D O I：
10.1016/j.pathol.2021.05.096
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：371 / 374
页数：4
相关论文
共 50 条
  • [1] Metastatic Uterine Leiomyosarcoma With MDM2 Amplification Mimicking Dedifferentiated Liposarcoma: A Diagnostic Pitfall
    Agaimy, Abbas
    Frohnauer, Judith
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2015, 34 (02) : 177 - 179
  • [2] Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma
    Bill, Kate Lynn J.
    Seligson, Nathan D.
    Hays, John L.
    Awasthi, Achal
    Demoret, Bryce
    Stets, Colin W.
    Duggan, Megan C.
    Bupathi, Manojkumar
    Brock, Guy N.
    Millis, Sherri Z.
    Shakya, Reena
    Timmers, Cynthia D.
    Wakely, Paul E., Jr.
    Pollock, Raphael E.
    Chen, James L.
    ONCOLOGIST, 2019, 24 (07): : 989 - 996
  • [3] Relevance of FNCLCC Grade and MDM2 Amplification Levels in Dedifferentiated Liposarcoma
    Jour, G.
    Gullet, A.
    Liu, M.
    Hoch, B. L.
    LABORATORY INVESTIGATION, 2014, 94 : 19A - 19A
  • [4] Relevance of FNCLCC Grade and MDM2 Amplification Levels in Dedifferentiated Liposarcoma
    Jour, G.
    Gullett, A.
    Liu, M.
    Hoch, B. L.
    MODERN PATHOLOGY, 2014, 27 : 19A - 19A
  • [5] Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
    Grifasi, Carlo
    Calogero, Armando
    Carlomagno, Nicola
    Campione, Severo
    D'Armiento, Francesco Paolo
    Renda, Andrea
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [6] Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
    Carlo Grifasi
    Armando Calogero
    Nicola Carlomagno
    Severo Campione
    Francesco Paolo D’Armiento
    Andrea Renda
    World Journal of Surgical Oncology, 11
  • [7] DEGREE OF MDM2 AMPLIFICATION AFFECTS CLINICAL OUTCOMES IN DEDIFFERENTIATED LIPOSARCOMA.
    Seligson, N. D.
    Bill, K. L. J.
    Hays, J. L.
    Demoret, B.
    Stets, C. W.
    Duggan, M.
    Bupathi, M.
    Shakya, R.
    Timmers, C.
    Walely, P. E.
    Pollock, R. E.
    Chen, J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S38 - S38
  • [8] The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma
    Ichikawa, Jiro
    Kawasaki, Tomonori
    Onohara, Kojiro
    Kanno, Satoshi
    Wako, Masanori
    Ochiai, Satoshi
    Aoki, Kaoru
    Haro, Hirotaka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH
    Al-Maghraby, Hatem Q.
    Khalbuss, Walid E.
    Rao, Uma N. M.
    Cieply, Kathleen
    Dacic, Sanja
    Monaco, Sara E.
    CYTOJOURNAL, 2010, 7
  • [10] MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma
    Ware, Patrick L.
    Snow, Anthony N.
    Gvalani, Maya
    Pettenati, Mark J.
    Qasem, Shadi A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (03) : 334 - 341
12345